BX Swiss TOP 30 CHF
1.196,02
PKT
+10,70
PKT
+0,90
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
11.07.22 | Roche Neutral | UBS AG | |
08.07.22 | Holcim Neutral | JP Morgan Chase & Co. | |
08.07.22 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
08.07.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
08.07.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
08.07.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
08.07.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
07.07.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
07.07.22 | Roche Hold | Jefferies & Company Inc. | |
06.07.22 | Swiss Re Sector Perform | RBC Capital Markets | |
06.07.22 | UBS Sector Perform | RBC Capital Markets | |
06.07.22 | UBS Outperform | RBC Capital Markets | |
06.07.22 | UBS Hold | Jefferies & Company Inc. | |
06.07.22 | UBS Buy | Jefferies & Company Inc. | |
06.07.22 | Swiss Re Hold | Jefferies & Company Inc. | |
06.07.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
05.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
05.07.22 | UBS Neutral | UBS AG | |
05.07.22 | Richemont Outperform | RBC Capital Markets | |
05.07.22 | UBS Underweight | JP Morgan Chase & Co. | |
05.07.22 | UBS Overweight | JP Morgan Chase & Co. | |
04.07.22 | Givaudan Neutral | UBS AG | |
04.07.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
01.07.22 | UBS Outperform | RBC Capital Markets | |
01.07.22 | UBS Sector Perform | RBC Capital Markets | |
01.07.22 | Novartis Neutral | UBS AG | |
01.07.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
01.07.22 | UBS Outperform | Credit Suisse Group | |
01.07.22 | Holcim Hold | Jefferies & Company Inc. | |
01.07.22 | Zurich Insurance Overweight | Barclays Capital | |
01.07.22 | Swiss Re Equal Weight | Barclays Capital | |
30.06.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
30.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
29.06.22 | Givaudan Hold | Deutsche Bank AG | |
29.06.22 | UBS Hold | Deutsche Bank AG | |
29.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
29.06.22 | Givaudan Underperform | Jefferies & Company Inc. | |
29.06.22 | Novartis Sell | Deutsche Bank AG | |
29.06.22 | UBS Neutral | Goldman Sachs Group Inc. | |
29.06.22 | Swisscom Neutral | JP Morgan Chase & Co. |